Criticism is coming out that top-ranked domestic pharmaceutical companies are falling into income dealer of multinational pharmaceutical companies
There are growing concerns because many listed domestic pharmaceutical companies show increasing sales through importing products of multinational pharmaceutical companies.
According to the analysis result of current status of sales of 44 listed pharmaceutical companies in the KOSPI and KOSDAQ w...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
